1. The document discusses sample size calculation for various study designs including cross-sectional studies, case-control studies, and clinical trials. It provides the key formulas and parameters involved in sample size calculation including confidence level, precision, power, and Z-values.
2. Several examples are provided to demonstrate how to calculate the minimum required sample size given information about the study design, variables, expected outcomes, confidence level, and power.
3. Key factors that determine sample size are confidence level, precision or minimum detectable difference, power, and values of outcomes in pilot or previous studies. The appropriate formulas are selected based on the study design and scale of measurement of variables.
This presentation will address the issue of sample size determination for social sciences. A simple example is provided for every to understand and explain the sample size determination.
When you perform a hypothesis test in statistics, a p-value helps you determine the significance of your results. ... The p-value is a number between 0 and 1 and interpreted in the following way: A small p-value (typically ≤ 0.05) indicates strong evidence against the null hypothesis, so you reject the null hypothesis.
This presentation will address the issue of sample size determination for social sciences. A simple example is provided for every to understand and explain the sample size determination.
When you perform a hypothesis test in statistics, a p-value helps you determine the significance of your results. ... The p-value is a number between 0 and 1 and interpreted in the following way: A small p-value (typically ≤ 0.05) indicates strong evidence against the null hypothesis, so you reject the null hypothesis.
Sample size calculation in medical researchKannan Iyanar
A short description on estimation of sample size in health care research. It describes the basic concepts in sample size estimation and various important formulae used for it.
Sensitivity, specificity and likelihood ratiosChew Keng Sheng
A short tutorial on sensitivity, specificity and likelihood ratios. In this presentation, I demonstrate why likelihood ratios are better parameters compared to sensitivity and specificity in real world setting.
Sample size calculation in medical researchKannan Iyanar
A short description on estimation of sample size in health care research. It describes the basic concepts in sample size estimation and various important formulae used for it.
Sensitivity, specificity and likelihood ratiosChew Keng Sheng
A short tutorial on sensitivity, specificity and likelihood ratios. In this presentation, I demonstrate why likelihood ratios are better parameters compared to sensitivity and specificity in real world setting.
The number that divides the normal distribution into region where we will reject the null hypothesis and the region where we fail to reject the null hypothesis. For normal distribution Z at 5% level of significance (z= plus-minus 1.96) is often referred to as the critical value (or critical region).
Steps of hypothesis testingSelect the appropriate testSo far.docxdessiechisomjj4
Steps of hypothesis testing
Select the appropriate test
So far we’ve learned a couple variation on z- and t-tests
See next slide for how to select
State your research hypothesis and your null hypothesis
State them in English
Then in math
Describe the NULL distribution
Starting here is where you be a skeptic and assume the null is true!
For one-sample tests, you will need to determine μ
(For two-tailed tests, you don’t need to worry about μ)
Compute the relevant standard error
Determine your critical value(s)
Keep in mind whether it is a directional or non-directional test
Compute the test statistic
Compare the test stat to the critical value(s) and make your decision
When to use each test
All of these tests require that the sampling distribution is normal
Either because population is normal or, thanks to central limit theorem, sample size is very large
All of these tests require that the measures be quantitative variables, that is interval/ratio
(Not all quantitative variables are normal, BUT all normal variables are quantitative. So if someone tells you a variable is normal, you know it is also quantitative.)
When to use each test, cont’d
1 Sample z-test
Comparing one sample mean to a population mean
And you do know σ (population SD)
2 sample z-test
Comparing two sample means to each other
And you do know σM1-M2 (standard error of difference of means)
1 sample t-test
Comparing one sample mean to a population mean
You only know s (sample SD)
2 sample t-test
Comparing two sample means to each other
You only know s1 and s2 (sample SDs)
Dependent sample t-test
You have two scores coming from each person, such as if you measured them before and after an experimental manipulation.
Compute the differences between the two scores, then treat like a 1 sample t
What is α?
Put on your skeptic’s hat: you believe the null hypothesis is true
But you’re willing to be convinced you’re wrong
If the test statistic is sufficiently improbable, you will change your mind and decide the null hypothesis is false
What is “sufficiently” improbable?
When your test statistic is more extreme than your critical values
Critical values are selected so that only a small fraction of the entire distribution is more extreme than the critical values
This “small fraction” is called α
Conventionally, α is usually set to .05, that is 5%
Directionality of a test
Is a test simply about whether there a difference, regardless of direction?
If so, it is a non-directed, or undirected, or two-tailed test
Your α must be evenly split between the two tails
For the conventional α = .05, that means each tail should have .025 or 2.5% of the total distribution
Is the test predicting one mean will be bigger than another? Or is it predicting one mean will be less than another?
If so, it a directional, or directed, or one-tailed test
Put all your α in a single tail
Special note on one-tailed tests
Step 3 of our procedure is a little awkward when we have one-tailed tests
How do you descr.
Sample size Calculation:
Objectives:
Calculate sample size according to particular type of research, and purpose.
Identify and select various software to calculate sample size according to particular type of research, and purpose.
Why to calculate sample size?
To show that under certain conditions, the hypothesis test has a good chance of showing a desired difference (if it exists)
To show to the IRB committee and funding agency that the study has a reasonable chance to obtain a conclusive result
To show that the necessary resources (human, monetary, time) will be minimized and well utilized.
Most Important: sample size calculation is an educated guess
It is more appropriate for studies involving hypothesis testing
There is no magic involved; only statistical and mathematical logic and some algebra
Researchers need to know something about what they are measuring and how it varies in the population of interest.
SAMPLE SIZE:
How many subjects are needed to assure a given probability of detecting a statistically significant effect of a given magnitude if one truly exists?
POWER:
If a limited pool of subjects is available, what is the likelihood of finding a statistically significant effect of a given magnitude if one truly exists?
Before We Can Determine Sample Size We Need To Answer The Following:
1. What is the primary objective of the study?
2. What is the main outcome measure?
Is it a continuous or dichotomous outcome?
3. How will the data be analyzed to detect a group difference?
4. How small a difference is clinically important to detect?
5. How much variability is in our target population?
6. What is the desired and ?
7. What is the anticipated drop out and non-response % ?
Where do we get this knowledge?
Previous published studies
Pilot studies
If information is lacking, there is no good way to calculate the sample size.
Type I error: Rejecting H0 when H0 is true
: The type I error rate.
Type II error: Failing to reject H0 when H0 is false
: The type II error rate
Power (1 - ): Probability of detecting group difference given the size of the effect () and the sample size of the trial (N).
Estimation of Sample Size by Three ways:
By using
(1) Formulae (manual calculations)
(2) Sample size tables or Nomogram
(3) Softwares.
SAMPLE SIZE FOR ADEQUATE PRECISION:
In a descriptive study,
Summary statistics (mean, proportion)
Reliability (or) precision
By giving “confidence interval”
Wider the C.I – sample statistic is not reliable and it may not give an accurate estimate of the true value of the population parameter.
Sample size calculation for cross sectional studies/surveys:
Cross sectional studies or cross sectional survey are done to estimate a population parameter like prevalence of some disease in a community or finding the average value of some quantitative variable in a population.
Sample size formula for qualitative variable and quantities variable are different.
Please Subscribe to this Channel for more solutions and lectures
http://www.youtube.com/onlineteaching
Chapter 8: Hypothesis Testing
8.1: Basics of Hypothesis Testing
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. The NecessityThe Necessity
Results become invalid if study doneResults become invalid if study done
on smaller size than requiredon smaller size than required
Un-necessary large size avoidedUn-necessary large size avoided
3. Pre-requisitesPre-requisites
Statistician requires some informationStatistician requires some information
Some of this can be given from records/Some of this can be given from records/
literature/ pilotliterature/ pilot
Some information requires knowledge ofSome information requires knowledge of
basic statisticsbasic statistics
In analytical / experimental studiesIn analytical / experimental studies
sample size is different for hypothesissample size is different for hypothesis
testing and for testing the differencetesting and for testing the difference
4. αα errorerror
αα is Significance level of a test. It isis Significance level of a test. It is
probability of rejecting a true nullprobability of rejecting a true null
hypothesis. Also called “Type-I Error”hypothesis. Also called “Type-I Error”
Commonly accepted level of alphaCommonly accepted level of alpha
error is: 0.05 or 0.10error is: 0.05 or 0.10
= 5% or 10%= 5% or 10%
In clinical trial a largeIn clinical trial a large αα errorerror
would lead to bringing a uselesswould lead to bringing a useless
drug in marketdrug in market
5. Confidence LevelConfidence Level
The probability of correctly accepting aThe probability of correctly accepting a
TRUE NH Denoted by 1-TRUE NH Denoted by 1- αα or 100 (or 100 ( 1-1- αα))
WhenWhen αα is decided, Conf. Level isis decided, Conf. Level is
automatically fixed.automatically fixed.
AlphaAlpha CLCL
5%5% 95%95%
10%10% 90%90%
6. Confidence LevelConfidence Level
Higher the confidence level, higher isHigher the confidence level, higher is
the sample size.the sample size.
Confidence Level
Sample
Size
7. BetaBeta ((ß)
The probability of failing to reject falseThe probability of failing to reject false
null hypothesis. It is also called “Type-null hypothesis. It is also called “Type-
II Error”II Error”
Commonly accepted levels of BetaCommonly accepted levels of Beta
error are: 0.1 , 0.2error are: 0.1 , 0.2
In terms of % : 10%, 20%In terms of % : 10%, 20%
In a clinical trial a largeIn a clinical trial a large ß errorerror
would lead to preventing a goodwould lead to preventing a good
drug from marketdrug from market
8. Power of A TestPower of A Test
The probability of correctly rejecting aThe probability of correctly rejecting a
false null hypothesis. It is denoted byfalse null hypothesis. It is denoted by
1-1- ßß In terms of % it is 100 x (1-In terms of % it is 100 x (1- ß)ß)
WhenWhen ßß is selected, Power of Test isis selected, Power of Test is
automatically fixed.automatically fixed.
BetaBeta PowerPower
10%10% 90%90%
20%20% 80%80%
9. Power of A TestPower of A Test
Higher the Power of Test, Higher isHigher the Power of Test, Higher is
the Sample Sizethe Sample Size
Power of Test
Sample
Size
10. Z valuesZ values
zz 1-1- αα /2/2 , z, z 1-1- αα , z, z 1-1- ßß
Represent the number of standardRepresent the number of standard
errors from the mean .errors from the mean .
zz 1-1- αα /2/2 and z zand z z 1-1- αα are the functions of theare the functions of the
confidence level, whileconfidence level, while
zz 1-1- ßß is the function of the power of theis the function of the power of the
test.test.
In this presentation Z1, Z2 will be usedIn this presentation Z1, Z2 will be used
for Zfor Z αα andand ZZ ßß respectively.respectively.
12. PrecisionPrecision
Difference between Guestimate of aDifference between Guestimate of a
variable and minimum/ maximumvariable and minimum/ maximum
valuevalue
When expressed as absolute value itWhen expressed as absolute value it
is called “Absolute Precision”is called “Absolute Precision”
GuestimateGuestimate
13. Relative PrecisionRelative Precision
When “Absolute Precision” is
expressed not in absolute terms, but
as % of Guestimate, it is called
“Relative Precision”
Other things equal, lesser the
value of precision, more is the
sample size required
16. Study type Objective Variable Information
required
Clinical trial
(Superiority
design)
5. Test
hypothesis
P1=P2
P1 and P2
measured
on
NOMINAL
Scale
P1, P2, Z1,
Z26. Estimate
difference
P1 , P2
7. Test
Hypothesis
M1=M2
M1 and M2
measured
on RATIO
scale
M1, M2, µ1,
µ2, Z1, Z28. Estimate
difference
M1=M2
17.
18.
19. 1. Epi Info
2. Open EPI
3. Power & Sample size
Calculator
20.
21.
22.
23. 1. Estimate Population P1. Estimate Population P
Cross sectional studyCross sectional study
Z1 is the corresponding value for setZ1 is the corresponding value for set
level of confidencelevel of confidence
P is guestimate of population proportionP is guestimate of population proportion
24. Example-1Example-1
In an epidemic, investigator wants toIn an epidemic, investigator wants to
know proportion of persons affectedknow proportion of persons affected
with 2 percent absolute precision andwith 2 percent absolute precision and
95% confidence. The guestimated P is95% confidence. The guestimated P is
4%4%
Here : P = 4%Here : P = 4%
Confidence is 95% so: Z = 1.96Confidence is 95% so: Z = 1.96
Absolute precision: d = 2Absolute precision: d = 2
26. 2.: Estimate Population2.: Estimate Population
MM
Cross sectional studyCross sectional study
M is Mean, aM is Mean, a
quantitative variablequantitative variable
measured onmeasured on
RATIO scaleRATIO scale
d is absoluted is absolute
precision.precision.
S is SD of MS is SD of M
Guestimate of MGuestimate of M
and its SD (S) isand its SD (S) is
requiredrequired
27. Example-2Example-2
We want to
estimate mean
Hb% of female
employees of
an organization
based on
sample.
Information
available:
Guestimate M =10
Guestimate of SD: (S)
= 3.0
Confidence level
95%, so: Z =1.96
Precision expected:
0.5
28. Calculation: Example-2Calculation: Example-2
1.961.9622
x 3x 322
n = -----------------n = -----------------
0.50.522
= 138.29= 138.29
Note: Mean of the
variable is NOT
required for
calculation of sample
size here. But is
required to arrive at
“d”
29. 3. Test NH OR=1: Case Control Study3. Test NH OR=1: Case Control Study
Outcome: NOMINAL variableOutcome: NOMINAL variable
Where:Where:
r = Ratio of controls tor = Ratio of controls to
casescases
Z1: Z value associatedZ1: Z value associated
with set level alphawith set level alpha
errorerror
Where:Where:
Z2= Z value for setZ2= Z value for set
level of beta errorlevel of beta error
P1, P2= ProbabilityP1, P2= Probability
exposure cases/exposure cases/
ControlsControls
P = P1+P2/ 2P = P1+P2/ 2
30. Example-3Example-3
In a pilot studyIn a pilot study
(hypothetical) it was(hypothetical) it was
found that 8% diabeticsfound that 8% diabetics
had family history,had family history,
while 2% % non-while 2% % non-
diabetics had familydiabetics had family
history. A large study ishistory. A large study is
planned What will beplanned What will be
minimum sample sizeminimum sample size
required?required?
Here:Here:
r =1r =1
Alpha = 0.05; so:Alpha = 0.05; so:
Z1= 1.96Z1= 1.96
Beta = 0.2 so; so: Z2Beta = 0.2 so; so: Z2
= 0.84= 0.84
P1 =0.08, P2=0.02P1 =0.08, P2=0.02
P = 0.05P = 0.05
32. 44. Estimate OR: Case Control Study. Estimate OR: Case Control Study
Outcome: NOMINAL variableOutcome: NOMINAL variable
Example-4Example-4: In example-3 (Family: In example-3 (Family
H/O diabetes), if objective is EstimateH/O diabetes), if objective is Estimate
OR, we use:OR, we use:
ε is relative precision (=0.5 forε is relative precision (=0.5 for
example)example)
Putting values n = 517Putting values n = 517
33. 5. Testing hypothesis P1=P25. Testing hypothesis P1=P2
Clinical trialClinical trial
P1 and P2 are outcome variablesP1 and P2 are outcome variables
measured on NOMINAL scale. P =measured on NOMINAL scale. P =
(P1+P2)/2(P1+P2)/2
Z1 is Z value corresponding to ConfidenceZ1 is Z value corresponding to Confidence
levellevel
Z2 is Z value corresponding to power ofZ2 is Z value corresponding to power of
34. Example-5Example-5
Pilot: Complication rates: new methodPilot: Complication rates: new method
(5%) and control surgical method (15%)(5%) and control surgical method (15%)
What would be required minimum sampleWhat would be required minimum sample
size to test NH of P1= P2 againstsize to test NH of P1= P2 against
alternate hypothesis of P1<P2alternate hypothesis of P1<P2
Z1 = 1.65 (for one sided hypothesis)Z1 = 1.65 (for one sided hypothesis)
Z2 = 0.84 (Power of test = 80%)Z2 = 0.84 (Power of test = 80%)
35. Information: Example-5Information: Example-5
P1, P2: Proportion of outcome in test andP1, P2: Proportion of outcome in test and
control intervention. 5 % (0.05) and 15%control intervention. 5 % (0.05) and 15%
(0.15) respectively(0.15) respectively
P =(P1+P2)/ 2= 10% = (0.10)P =(P1+P2)/ 2= 10% = (0.10)
Confidence level: for Z1: 95% (OneConfidence level: for Z1: 95% (One
sided) so,sided) so, αα = 0.05= 0.05 ,, so: Z1= 1.65so: Z1= 1.65
(If two sided, Z will be =1.96)(If two sided, Z will be =1.96)
Power of test 80% So, Z2 = 0.84Power of test 80% So, Z2 = 0.84
36. Calculation: Example-5Calculation: Example-5
A. Testing NH P1=P2A. Testing NH P1=P2
Using formula given below:Using formula given below:
n = Study group=Control group = 30n = Study group=Control group = 30
37. Example-6Example-6
Objective: Estimating difference P1, P2Objective: Estimating difference P1, P2
With absolute precision of 2 %With absolute precision of 2 %
n= study group=control group= 642n= study group=control group= 642